Meropenem Dosing for CrCl 24 mL/min
For a patient with creatinine clearance of 24 mL/min, administer meropenem at one-half the standard recommended dose every 12 hours 1.
Specific Dosing Based on Infection Type
The FDA-approved dosing for renal impairment with CrCl 10-25 mL/min is straightforward:
- For complicated skin and skin structure infections (cSSSI): 250 mg IV every 12 hours (half of the standard 500 mg dose)
- For complicated intra-abdominal infections: 500 mg IV every 12 hours (half of the standard 1 gram dose)
Since your patient has a CrCl of 24 mL/min, they fall into the 10-25 mL/min category per the FDA label 1.
Administration Details
- Administer as intravenous infusion over 15-30 minutes
- Alternatively, may give as IV bolus injection over 3-5 minutes for the 500 mg dose 1
- The dosing interval change from every 8 hours to every 12 hours is critical—this prevents drug accumulation and potential toxicity
Important Clinical Considerations
Renal function monitoring is essential. If the patient's renal function deteriorates further to CrCl <10 mL/min, the dosing must be adjusted again to one-half the recommended dose every 24 hours 1. Research confirms that meropenem elimination half-life increases from approximately 1.5 hours in normal renal function to 5 hours when CrCl is <30 mL/min 2.
For Pseudomonas aeruginosa infections specifically: Even with renal impairment, you may need higher doses. The standard dose for P. aeruginosa is 1 gram every 8 hours in normal renal function, so the adjusted dose would be 500 mg every 12 hours for your patient with CrCl 24 mL/min 1.
Common Pitfalls to Avoid
- Do not use standard dosing without adjustment—this significantly increases seizure risk, particularly in patients with renal impairment 1
- Avoid co-administration with valproic acid/divalproex sodium—meropenem reduces valproic acid levels and increases breakthrough seizure risk 1
- Do not mix with probenecid—it inhibits renal excretion of meropenem and is not recommended 1
- Monitor for thrombocytopenia—this has been observed specifically in patients with renal dysfunction 1
Hemodialysis Consideration
If your patient progresses to requiring hemodialysis, the dosing strategy changes entirely: administer one-half the recommended dose after each hemodialysis session, as dialysis significantly removes meropenem (shortening half-life from 7 hours to 2.9 hours) 2.